Helsinki, Finland

Päivi Tammela

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.8

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Päivi Tammela: Innovator in Medical Biotechnology

Introduction

Päivi Tammela is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of medical biotechnology, particularly in the development of compounds for treating bacterial infections. With a total of 2 patents, Tammela's work focuses on innovative solutions that address critical health challenges.

Latest Patents

Tammela's latest patents include a class of DNA gyrase and/or topoisomerase IV inhibitors with activity against gram-positive and gram-negative bacteria. This invention relates to compounds with a general formula (I), processes for their preparation, and pharmaceutical compositions containing these compounds as active ingredients. These innovations are aimed at treating bacterial infections in humans and warm-blooded animals. Another significant patent involves a medical product comprising a bioactive molecule immobilized to nanofibrillar cellulose. This patent outlines a method for preparing a medical product for covering tissue, which includes covalently bonding a bioactive molecule to nanofibrillar cellulose.

Career Highlights

Throughout his career, Tammela has worked with esteemed institutions such as the University of Ljubljana and the Szeged Biological Research Center. His experience in these organizations has contributed to his expertise in medical biotechnology and innovation.

Collaborations

Tammela has collaborated with notable professionals in his field, including Tihomir Tomašič and Nace Zidar. These collaborations have further enhanced his research and development efforts.

Conclusion

Päivi Tammela is a distinguished inventor whose work in medical biotechnology has led to valuable patents aimed at combating bacterial infections. His contributions reflect a commitment to advancing healthcare through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…